Edition:
India

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

28.27USD
22 Jun 2018
Change (% chg)

$0.70 (+2.54%)
Prev Close
$27.57
Open
$27.59
Day's High
$28.32
Day's Low
$27.42
Volume
1,043,474
Avg. Vol
292,467
52-wk High
$41.75
52-wk Low
$18.28

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.87 December 23 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 3
(2) OUTPERFORM 6 6 6 6
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.75 1.75 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 6 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 15.10
Year Ending Dec-19 8 40.56 142.01 0.00 40.65
Earnings (per share)
Quarter Ending Jun-18 7 -0.87 -0.76 -0.93 -0.78
Quarter Ending Sep-18 7 -0.87 -0.75 -0.97 -0.87
Year Ending Dec-18 7 -3.62 -3.26 -3.84 -3.21
Year Ending Dec-19 7 -2.94 -1.54 -3.98 -2.21

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 0.00 0.00 0.00 0.00 15.10
Year Ending Dec-19 40.56 40.56 40.56 41.33 40.65

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings